A Prospective Study of Traditional Chinese Medicine Prevention and Treatment Schemes for Undifferentiated Connective Tissue Disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2200005775

Enrollment

Unknown

Registered

2021-07-19

Start date

2021-07-20

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Undifferentiated Connective Tissue Disease (UCTD)

Interventions

Control group:Symptomatic treatment

Experimental group:Symptomatic treatment combined with the Yunpi Yangyin Jiedu Qushi Decoction

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Have symptoms and signs of connective tissue disease (CTD); 2. Antinuclear antibody positive; 3. Does not meet any CTD diagnosis; 4. The medical history is greater than or equal to 2 years; 5. It is in line with the syndrome of spleen deficiency and damp toxin internal resistance and yin deficiency in traditional Chinese medicine; 6. Aged 18 to 65 years; 7. Patients informed and agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe organ or mental disorder. 2. Patients who are allergic to or have contraindications to the drugs involved in the study protocol.

Design outcomes

Primary

Measure	Time frame
CTD conversion rate;	—

Secondary

Measure	Time frame
Antinuclear antibody;Erythrocyte sedimentation rate;Rheumatoid factor;Immunoglobulin G;Anti-dsDNA antibody;Hemoglobin;Anti-RNP antibody;Urine red blood cell;C-reactive protein;Anti-Sm antibody;Anti-SSB antibody;White blood cell;Urine protein;Liver function;Platelet;Anti-SSA antibody;	—

Countries

China

Contacts

Public ContactWen Chengping

ZHEJIANG CHINESE MEDICAL UNIVERSITY

wengcp@163.com+86 13906514781

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026